KRTX - Karuna Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRTX is currently covered by 19 analysts with an average price target of $370.82. This is a potential upside of $40.99 (12.43%) from yesterday's end of day stock price of $329.83.

Karuna Therapeutics's activity chart (see below) currently has 68 price targets and 103 ratings on display. The stock rating distribution of KRTX is 85.25% BUY and 14.75% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 91.46% with an average time for these price targets to be met of 196.71 days.

Highest price target for KRTX is $330, Lowest price target is $225, average price target is $370.82.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 11-Mar-2024. First documented stock forecast 23-Jul-2019.

Currently out of the existing stock ratings of KRTX, 52 are a BUY (85.25%), 9 are a HOLD (14.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

330

$0.17 (0.05%)

330

2 months 15 days ago

13/15 (86.67%)

$10.81 (3.39%)

281

Hold

330

$0.17 (0.05%)

330

3 months 6 days ago

2/4 (50%)

$11.41 (3.58%)

86

Hold

245

$-84.83 (-25.72%)

245

4 months ago

12/13 (92.31%)

$-69 (-21.97%)

168

Buy

295

$-34.83 (-10.56%)

280

5 months 4 days ago

2/3 (66.67%)

$-22.85 (-7.19%)

148

Buy

330

$0.17 (0.05%)

280

5 months 4 days ago

5/6 (83.33%)

$12.15 (3.82%)

278

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRTX (Karuna Therapeutics) average time for price targets to be met?

On average it took 196.71 days on average for the stock forecasts to be realized with a an average price target met ratio 91.46

Which analyst has the current highest performing score on KRTX (Karuna Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on KRTX (Karuna Therapeutics)?

Raghuram Selvaraju has 3 price targets and 16 ratings on KRTX

Which analyst is the currently most bullish on KRTX (Karuna Therapeutics)?

Mohit Bansal with highest potential upside - $55.91

Which analyst is the currently most reserved on KRTX (Karuna Therapeutics)?

Chris Howerton with lowest potential downside - -$146.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?